- Home
- VSCO vs IDYA Comparison
VSCO vs IDYA Comparison
Compare VSCO & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSCO
- IDYA
- Stock Information
- Founded
- VSCO 1977
- IDYA 2015
- Country
- VSCO United States
- IDYA United States
- Employees
- VSCO N/A
- IDYA N/A
- Industry
- VSCO Clothing/Shoe/Accessory Stores
- IDYA Biotechnology: Pharmaceutical Preparations
- Sector
- VSCO Consumer Discretionary
- IDYA Health Care
- Exchange
- VSCO Nasdaq
- IDYA Nasdaq
- Market Cap
- VSCO 2.2B
- IDYA 2.0B
- IPO Year
- VSCO N/A
- IDYA 2019
- Fundamental
- Price
- VSCO $27.96
- IDYA $21.85
- Analyst Decision
- VSCO Hold
- IDYA Strong Buy
- Analyst Count
- VSCO 12
- IDYA 13
- Target Price
- VSCO $40.33
- IDYA $53.67
- AVG Volume (30 Days)
- VSCO 2.0M
- IDYA 943.3K
- Earning Date
- VSCO 03-05-2025
- IDYA 02-13-2025
- Dividend Yield
- VSCO N/A
- IDYA N/A
- EPS Growth
- VSCO 54.91
- IDYA N/A
- EPS
- VSCO 1.95
- IDYA N/A
- Revenue
- VSCO $6,207,000,000.00
- IDYA $7,000,000.00
- Revenue This Year
- VSCO $2.99
- IDYA $111.81
- Revenue Next Year
- VSCO $1.74
- IDYA $240.55
- P/E Ratio
- VSCO $14.32
- IDYA N/A
- Revenue Growth
- VSCO 1.42
- IDYA N/A
- 52 Week Low
- VSCO $15.12
- IDYA $19.96
- 52 Week High
- VSCO $48.73
- IDYA $47.72
- Technical
- Relative Strength Index (RSI)
- VSCO 20.67
- IDYA 43.52
- Support Level
- VSCO $31.65
- IDYA $19.96
- Resistance Level
- VSCO $33.22
- IDYA $21.65
- Average True Range (ATR)
- VSCO 1.46
- IDYA 1.09
- MACD
- VSCO -0.40
- IDYA -0.07
- Stochastic Oscillator
- VSCO 3.39
- IDYA 33.57
About VSCO Victorias Secret & Co.
Victoria's Secret & Co is a specialty retailer of lingerie, pajamas, and beauty products with prestige fragrances and body care. It serves customers at its Lingerie and Beauty stores around the globe and online enabling them to shop the brand anywhere and anytime. The Company operates as a single segment designed to serve customers worldwide seamlessly through stores and online channels.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.